CFTR p.Gly1069Arg

Variant summary

Our verdict is Pathogenic.
+11 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 11 classification points (ACMG Germline Pathogenicity v2019). PS1PS3PM1PP5

The NM_000492.4(CFTR):c.3205G>A (p.Gly1069Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.000136 (AC=220) in the gnomAD database across 1,613,472 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.00087. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (no review stars). ClinVar reports functional evidence for this variant: "SCV001180539: Functional studies demonstrated that while the p.G1069R variant in CFTR does not impact protein maturation or conductance, it does reduce the probability of channel opening (Seibert FS et al. J. Biol. Chem., 1996 Jun;271:15139-45)." and additional evidence is available in ClinVar. This exact variant is curated in the UniProt human variants database as Uncertain Significance.

Frequency

Genomes: 𝑓 0.00024 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

CFTR
NM_000492.4 missense

Scores

3
8
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:16U:9

Conservation

PhyloP100: 6.85

Publications

55 publications found
Variant links:
Genes affected
CFTR (HGNC:1884): (CF transmembrane conductance regulator) This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017]
CFTR Gene-Disease associations (from GenCC):
  • congenital bilateral aplasia of vas deferens from CFTR mutation
    Inheritance: AR Classification: DEFINITIVE Submitted by: Natera
  • cystic fibrosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Myriad Women's Health, ClinGen, Natera, Orphanet
  • congenital bilateral absence of vas deferens
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary chronic pancreatitis
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000492.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 11 points.

PS1Same amino acid change as known pathogenic
Same AA change, 1-star ClinVar pathogenic — strong (PS1); ClinVar contains 1 P/LP entry with the same amino acid change (highest review level: 1 star).
PS3Functional studies show damaging effect
Well-established functional study supports damaging effect (PS3); SCV001180539: Functional studies demonstrated that while the p.G1069R variant in CFTR does not impact protein maturation or conductance, it does reduce the probability of channel opening (Seibert FS et al. J. Biol. Chem., 1996 Jun;271:15139-45).; SCV005906064: "Functional studies provide supporting evidence of the variant having a damaging effect on the gene or gene product." PMID:8662892; SCV000601092: Experimental studies indicate this variant induces an ion channel gating defect in the CFTR protein (PMIDs: 8662892 (1996), 22210114 (2012)).; SCV005418403: "Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product."; SCV000603016: "In vitro functional analyses demonstrate that this variant does not alter protein expression, but reduces channel function (Seibert 1996)." PMID: 8662892
PM1Mutational hot spot or critical domain
Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 16 pathogenic, 0 benign (OR vs. background: 165.0).
PP5Reputable source reports pathogenic
ClinVar 0-star pathogenic — supporting (PP5); ClinVar germline classification: Pathogenic/Likely Pathogenic, 0 star(s).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000492.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CFTR NM_000492.4
MANE Select
HGVSc / HGVSpc.3205G>Ap.Gly1069Arg
Exon rankExon 20 of 27
missense
Prot: NP_000483.3
CFTR-AS2 NR_199597.1
HGVSc / HGVSpn.177+4583C>T
Exon rankIntron 2 of 2
intron
Prot:

Ensembl Transcripts

CFTR ENST00000003084.11
TSL:1MANE Select
HGVSc / HGVSpc.3205G>Ap.Gly1069Arg
Exon rankExon 20 of 27
missense
Prot: ENSP00000003084.6UniProt: P13569-1
CFTR ENST00000699602.1
HGVSc / HGVSpc.3205G>Ap.Gly1069Arg
Exon rankExon 20 of 27
missense
Prot: ENSP00000514471.1UniProt: A0A8V8TNH2
CFTR ENST00000889206.1
HGVSc / HGVSpc.3118G>Ap.Gly1040Arg
Exon rankExon 19 of 26
missense
Prot: ENSP00000559265.1UniProt: A0ACI8SBR8

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.000243
AC:37
Hom:0
AN:151976
Cov:31
GnomAD2 exomes
AF: 0.000255
AC:64
AN:250934
GnomAD4 exome
AF: 0.000125
AC:183
Hom:0
AN:1461378
Cov:31
GnomAD4 genome
AF: 0.000243
AC:37
Hom:0
AN:152094
Cov:31
TOPMed (Bravo)
AF: 0.000264
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.000190
AC:60
Hom:0
AN:316230
Local & regional cohorts 7 sources
ABraOM SABE-WGS-1171
AF: 0.000427
AC:1
Hom:0
AN:2342
ChinaMAP Phase 1
AF: 0.000936
ESP6500 (Exome Variant Server)
AF: 0.000538
AC:7
AN:13006
Korea4K (4,157 Koreans)
AF: 0.000138
AC:1
AN:7224
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.0000160
AC:2
Hom:0
AN:122174
Turkish Variome
AF: 0.000744
AC:5
Hom:0
AN:6718
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.00134
AC:12
Hom:0
AN:8960
Showing 13 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.000104 *19614 0.00 *010412
BipEx
(Bipolar disorder (including schizoaffective))
0.000176 528414 0.000139 428844
Epi25
(Epilepsy)
0.000453 1941956 0.000254 1766876
SCHEMA
(Schizophrenia)
0.000283 32113184 0.000215 41190670
Showing 4 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
6
3
-
Cystic fibrosis (9)
3
2
-
CFTR-related disorder (5)
2
2
-
not provided (4)
2
-
-
Cystic fibrosis;C0238339:Hereditary pancreatitis;C0403814:Congenital bilateral aplasia of vas deferens from CFTR mutation;C2749757:Bronchiectasis with or without elevated sweat chloride 1 (2)
2
-
-
Cystic fibrosis;C0403814:Congenital bilateral aplasia of vas deferens from CFTR mutation (2)
1
-
-
Bronchiectasis with or without elevated sweat chloride 1 (1)
-
1
-
Hereditary pancreatitis (1)
-
1
-
not specified (1)

Computational Scores

AlphaGenome AVI
Pathogenic24
AlphaMissense
Benign0.31
BayesDel_addAF
Benign-0.037T
BayesDel_noAF
Uncertain0.13
CADD
Uncertain25
DANN
Benign0.89
DEOGEN2
Uncertain0.50T
Eigen
Uncertain0.24
Eigen_PC
Uncertain0.34
FATHMM_MKL
Pathogenic0.98D
GPN-Star LLR
N/A-7.4
GPN-Star score
N/A7.2
LIST_S2
Uncertain0.91D
M_CAP
Pathogenic0.33D
MetaRNN
Benign0.24T
MetaSVM
Uncertain-0.0072T
Mutation Taster
N/A11/89disease causing (ClinVar)
MutationAssessor
Benign1.3L
PhyloP100
Uncertain6.9
popEVE
Benign-3.0
PrimateAI
Pathogenic0.85D
PromoterAI
N/A-0.0040Neutral
PROVEAN
Benign0.14N
REVEL
Uncertain0.60
Sift
Benign0.48T
Sift4G
Benign0.094T
Varity_R
N/A0.57
VESM-3B
Benign-7.6
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.010
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.